Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,002 | 25,985 | 31,633 | 39,364 | 44,257 |
| Marketable Securities | 25,451 | N/A | N/A | N/A | N/A |
| Receivables | 544 | 1,091 | 1,013 | 1,077 | 1,827 |
| TOTAL | $83,976 | $28,010 | $33,509 | $41,839 | $47,076 |
| Non-Current Assets | |||||
| PPE Net | 11,489 | 12,015 | 12,551 | 13,016 | 13,567 |
| Intangibles | 38,944 | 1,941 | 2,036 | 2,132 | 2,473 |
| Other Non-Current Assets | 5,955 | 6,136 | 6,316 | 6,497 | 6,677 |
| TOTAL | $56,388 | $20,092 | $20,903 | $21,644 | $22,717 |
| Total Assets | $140,364 | $48,102 | $54,412 | $63,483 | $69,793 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 229 | 221 | 214 | N/A |
| Accounts payable and accrued liabilities | 1,445 | 4,110 | 4,332 | 4,455 | 5,111 |
| Accrued Expenses | 5,615 | 4,402 | 3,024 | 4,359 | 3,841 |
| Other current liabilities | 2,156 | N/A | N/A | N/A | 218 |
| TOTAL | $14,407 | $14,107 | $12,856 | $14,052 | $14,101 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 989 | 1,026 | 1,054 | N/A |
| Deferred Revenues | 5,191 | 5,366 | 5,279 | 5,025 | 4,931 |
| Other Non-Current Liabilities | 17,999 | 0 | 0 | 0 | 1,069 |
| TOTAL | $52,190 | $36,235 | $37,253 | $37,641 | $37,558 |
| Total Liabilities | $66,597 | $50,342 | $50,109 | $51,693 | $51,659 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,115 | 2,108 | 1,059 | 1,055 | 1,055 |
| Common Shares | 32 | 16 | 16 | 16 | 16 |
| Retained earnings | -157,674 | -144,731 | -137,557 | -128,853 | -121,149 |
| Other shareholders' equity | 2,546 | 2,593 | 2,591 | 2,594 | 2,606 |
| TOTAL | $73,767 | $-2,240 | $4,303 | $11,790 | $18,134 |
| Total Liabilities And Equity | $140,364 | $48,102 | $54,412 | $63,483 | $69,793 |